Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Deborah Collyar: What's In It for Patients?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Apr
29
Today In Oncology
AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS
MIBC Pembrolizumab With Trimodal Therapy for Bladder Preservation
Long-Term Outcomes With Taletrectinib in ROS1-Positive NSCLC
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Study Finds Prostate Cancer Overdiagnosis Rises ‘Substantially’ With Age
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo